The information on this website is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any peptide therapy or other compounds.
Sponsored by
Joaking Fitness - Entrendor personal
Anti-aging Neuropeptides Mitochondrial Peptides Under research

Epithalon

Also known as: Epitalon, Epithalone, Ala-Glu-Asp-Gly

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed from epithalamin, a substance produced by the pineal gland. Primarily investigated in longevity research for its ability to activate telomerase, elongate telomeres, and regulate circadian rhythm. Developed by the St. Petersburg Institute of Gerontology (Russia).

Mechanism of action

  • Telomerase activation: Stimulates telomerase enzyme in somatic cells, extending telomeres and delaying cellular senescence
  • Melatonin regulation: Normalizes melatonin production by the pineal gland
  • Antioxidant properties: Reduces oxidative stress and lipoperoxidation product levels
  • Neuroendocrine modulation: Regulates the hypothalamic-pituitary-gonadal axis

Uses & indications

  • Anti-aging: Potential extension of healthy lifespan
  • Sleep improvement and circadian rhythm regulation
  • Retinal protection: Studies in macular degeneration
  • Experimental oncology: Antiproliferative effects in tumor cell lines (in vitro)

Effects

Animal evidence: Studies in rodents at the St. Petersburg Gerontological Institute showed 24–33% median lifespan extension and reduced spontaneous tumor incidence.

Adverse effects: Minimal reported. Some anecdotal reports of vivid dreams, mild headache. No evidence of toxicity at standard doses.

Considerations & contraindications

  • Not approved by FDA/EMA; no large-scale human clinical trials
  • Telomerase activation could theoretically favor tumor cells (hypothetical risk)
  • Long-term effects in humans unknown
  • Do not use during pregnancy

Regulatory approval

Research peptide. Approved in Russia for limited geriatric use. Not approved in Western countries. Investigated by Vladimir Khavinson (Institute of Gerontology, St. Petersburg).

Dosage

Typical protocols: 5–10 mg/day for 10–20 days (cycle). Repeat 2–4 times/year.

Storage

Lyophilized: −20°C. Reconstituted: 4°C, use within 2–3 weeks.
Technical data
Regulatory status Under research
Molecular weight 390.35 Da
Half-life Corta (minutos–horas)
Administration routes Subcutánea, intramuscular, sublingual
Reconstitution ← Back to catalog

If you detect incorrect information, tell us what is wrong and provide a scientific source to support it.